Myositis Insights

Recent research has explored the effects of methyl 3,...

Latest Research

Recent research has explored the effects of methyl 3, 4-dihydrobenzoate on muscle fiber necroptosis and macrophage pyroptosis in inflammatory myopathies. Tang et al. (2025) This compound appears to regulate oxidative stress by impacting reactive oxygen species (ROS) levels and nuclear factor erythroid 2 related factor 2 (Nrf2) protein expression in muscle fibers, as seen in experimental autoimmune myositis Tang et al.

(2025)
. This suggests potential therapeutic benefits by reducing muscle damage. Managing oxidative stress is crucial in inflammatory myopathies, as it can lead to significant muscle damage. Compounds like methyl 3, 4-dihydrobenzoate may mitigate this effect by reducing ROS levels and modulating Nrf2 expression, potentially protecting muscle fibers and improving health outcomes. Further research is needed to fully understand these treatments' potential.

Clinical Trials

This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks:

Community News

Upcoming Events

APR
11
Myositis New Member OrientationOnline The Myositis Association β€’ Columbia, MD
APR
15
Home Infusion Therapy WebinarOnline Myositis Support and Understanding
MAY
02
Myositis Patient Advocacy WorkshopIn Person Myositis Support and Understanding
SEP
18
Global Myositis Patient ConferenceIn Person The Myositis Association β€’ Columbia, MD